Alpine Global Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Alpine Global Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-56,100	Closed	-$5K	–	639
2022 Q3	$5K	Hold	56,100	–	–	﹤0.01%	253
2022 Q2	$8K	Buy	+56,100	New	+$10.5K	﹤0.01%	293

Other funds holding BIOSW

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Alpine Global Management's BIOSW Position: Q4 2022 in Review

Alpine Global Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2022, closing a stake of 56,100 shares — an estimated $5K sold.

Alpine Global Management first reported a position in BIOSW in Q2 2022 and held it in 2 quarters. The position peaked at $8K in Q2 2022. 44 funds tracked by Wall St. Rank hold BIOSW as of Q4 2022.

Alpine Global Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
Alpine Global Management sold 56,100 BioPlus Acquisition Corp. Warrants shares in Q4 2022, an estimated $5K.
Alpine Global Management first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2022 and held it in 2 quarters.
Alpine Global Management's BioPlus Acquisition Corp. Warrants position peaked at $8K in Q2 2022.
44 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2022.

Based on Alpine Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.